Medical studies often involve comparing the toxicity and efficacy of d
rugs. Separately evaluating toxicity and efficacy, the usual practice,
does not correspond to how doctors manage patients and does not use t
he information provided in their bivariate relationship. This paper pr
esents methods for analysing the bivariate data. One method is based o
n assessing the benefit for patient values to lie in different regions
of the toxicity-efficacy plane. A second method includes patient thre
sholds for tolerating drugs. We propose dividing the toxicity-efficacy
plane into regions where patients are likely to tolerate the drug. Se
veral statistics are defined on these regions for measuring the toxic-
therapeutic relationship, and the bootstrap is proposed for estimating
their variances. We illustrate with treatment information available o
n rheumatoid arthritis patients.